Study on Cognitive Behavioral Therapy for Insomnia to Reduce Impulsivity and Risk Taking in Youths with Insomnia

What this Trial Is About

This research investigates the effects of Cognitive Behavioural Therapy for Insomnia CBT-I on impulsivity and risk-taking behaviors in youths aged 12 to 24 with insomnia. The study responds to evidence linking insomnia with impaired inhibitory control and adverse outcomes such as substance abuse and self-harm. It aims to evaluate whether CBT-I can improve impulsivity compared to a psychoeducation control in this population. Participants will be randomly assigned to receive either group-based CBT-I or a health-related psychoeducation control. The CBT-I involves six weekly 90-minute group sessions focusing on sleep hygiene, stimulus control, sleep restriction, relaxation, cognitive restructuring, and relapse prevention. The control group will also attend six weekly sessions covering general well-being, diet, and exercise information. Assessments occur before treatment, one week after the last session, and six months post-treatment to examine lasting effects. During the trial, researchers will measure changes in impulsivity using self-reports and objective tests, alongside sleep diary and actigraphy data. Cognitive performance tasks and ERP components related to impulsivity and risk-taking will also be evaluated at each time point. The study includes safety monitoring and requires participant compliance with the protocol over approximately seven weeks plus follow-up at six months.

Effects of CBT-I on Impulsivity and Risk Taking in Youths With Insomnia